Ubiquitech Software Corp (OTCMKTS:UBQU) an international technology and services firm that also has a stake in provided updates on development of a new CBD Oil. The new product will be developed exclusively for CannazALL™ brand and is expected to be priced under $100. The new affordable product, also termed as entry level product is developed to help more customers derive benefits of the products sold under CannazALL™ brand. The new CBD oil is expected to be launch on the Website in this month.

The details

Ubiquitech Software stated that the new CBD oil will be marketed under the brand CannazALL™ exclusive to It will be sold as a 20% High CBD Oil offered in an easy-to-measure and administer oral syringe that will contain 1 gram of CBD. The new product is being developed as a convenient entry level alternative to launch its CBD products to a large audience.’s CEO Tim Zorn said that with the addition of the new CBD oil, the company has a patented product at remarkable entry level cost of under $100. The price offers marketing edge to Ubiquitech and related firms as they will offer sophisticated domestically developed CBD oil at affordable price. It indicates more people can benefit from company’s products, which will also add to company’s revenues.

The expert speaks

James Ballas, the CEO of Ubiquitech, said that making more people know about CBD oil and its potential benefits is the main task of Ubiquitech. Increasing awareness will lead to increased sales. The team is thrilled when popular stations air their popular documentaries such as “Weed” as it details on CBD and potential benefits.

In last trading session, the stock price of UBQU declined more than 18% to close the trading session at $0.106. The decline came at a share volume of 704,767 compared to average share volume of 285,024.